6b-Hydroxy budesonide

CAS: 88411-77-2

Ref. 3D-FH23924

Información del producto

• Nombre: 6b-Hydroxy budesonide
• Sinónimos: (6b,11b,16a)-16,17-[Butylidenebis(oxy)]-6,11,21-trihydroxypregna-1,4-diene-3,20-dione, (6β,11β,16α)-16,17-[Butylidenebis(oxy)]-6,11,21-trihydroxypregna-1,4-diene-3,20-dione, 6b-Hydroxybudesonide, Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-6,11,21-trihydroxy-, (6β,11β,16α)-

Descripción

6b-Hydroxy budesonide is a drug that is metabolized to budesonide, which is a potent glucocorticoid. The pharmacokinetic profile of 6b-hydroxy budesonide was studied in animals and humans. This drug has minimal biliary excretion and is extensively metabolized by the liver. It has been shown to have anti-inflammatory effects, with cyp3a substrates being involved in its metabolism. 6b-Hydroxy budesonide binds to the glucocorticoid receptor, leading to DNA transcription and protein synthesis inhibition. 6b-Hydroxy budesonide has been used for the treatment of cirrhosis, as it helps to reduce the severity of symptoms such as nausea and vomiting.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 446.53 g/mol
• Fórmula: C₂₅H₃₄O₇
• Pureza: Min. 95%